Journal of Hematology and Blood Disorders

Dr. Baobing Zhao, Ph.D., is a Professor and Doctoral Supervisor at the School of Pharmaceutical Sciences, Shandong University, and a Taishan Scholar Distinguished Young Expert in Shandong Province. He specializes in molecular pharmacology, focusing on the regulation of the hematopoietic microenvironment, discovery and validation of novel drug targets, and screening of lead compounds for targeted therapies. Dr. Zhao has published over 60 SCI-indexed papers in leading journals, including Journal of Clinical Investigation, Developmental Cell, Advanced Science, and Leukemia. He holds several important academic and professional roles, serving as Deputy Head of the National Regenerative Medicine Professional Committee of the China Volunteer Association, Executive Director of the Shandong Pharmacological Society, Deputy Director of the Hematopoietic Reconstruction and Cellular Engineering Committee of the Shandong Stem Cell Society, and Director of the Cell Biology Society of Shandong Province. Additionally, he is a Young Member of the Teaching and Science Popularization Committee of the Chinese Pharmacological Society and a Member of the Multidisciplinary Joint Committee on Umbilical Cord Blood Clinical Applications of the Shandong Medical Association. Dr. Zhao also contributes to the scientific community as an Editorial Board Member of Pharmacology Discovery, MedMat, and Pharmaceutical Science Advances, and serves as a reviewer for leading journals such as Molecular Cell, Advanced Science, European Journal of Medicinal Chemistry, and Blood. He earned his Ph.D. in Science from Xiamen University and his Bachelor of Engineering from Northwest A&F University. Before joining Shandong University, he completed his postdoctoral training and later served as a Research Assistant Professor at the Feinberg School of Medicine, Northwestern University, USA. His research interests include the regulation of the hematopoietic microenvironment, discovery of novel drug targets, mechanisms of stem cell biology, and the development of stem cell exosome application technologies.

Research: Regulation of the hematopoietic microenvironment and related disease mechanisms, Screening of active lead compounds for new targets, Regulatory mechanisms of stem cell biology, Development of stem cell exosome application technologies  

Dr. Konstantin N. Konstantinov completed a MD and PhD at the Academy of Medicine, Sofia.  His medical and laboratory training in 3 different countries (Bulgaria, Denmark, and the US) has armed him with a doctorate in dermatology and clinical immunology, Board Certifications in three subspecialties (dermatology, internal medicine, rheumatology) and experience in basic immunology and translational clinical research. Dr. Konstantin N. Konstantinov work at The State Serum Institute, Copenhagen, the Autoimmune Disease Center at the Scripps Research Institute in La Jolla, California, and Albert Einstein College of Medicine in New York , shaped his career  as a rheumatologist and autoimmune disease expert. In 2003 Dr. Konstantinov joined the University of New Mexico where he is a Professor of Internal Medicine and Rheumatology. 

Research: Dr. Konstantin N. Konstantinov’s  clinical and research interests continue to focus on identification of Novel autoantibodies and biomarkers for autoimmune diseases The development of innovative diagnostic technologies The relationship of the autoimmune response to disease mechanisms Dr. Konstantinov is a member of the IUIS/WHO/AF/CDC Autoantibody Standardization Committee in Rheumatic and Related Disorders, which is responsible for making evidence-based recommendations in autoimmune rheumatic diseases worldwide.  

Dr.  Han-Mou Tsai is a Professor of Medicine and Pathology and holds the title of M. Elaine Eyster M.D. Professor of Hematology at Pennsylvania State University Milton S. Hershey College of Medicine. He has authored many research articles and is an author on the subject of thrombotic thrombocytopenic purpura and hemolytic uremic synrome in a major hematology textbook. He has served as a member of the editorial or advisory board of major hematology journals. He is a member of the American Society of Hematology and the International Society of Thrombosis and Hemostasis.

Research: Dr. Han-Mou Tsai’s research interests include: Von Willebrand factor ADAMTS13  Shear stress Thrombotic thrombocytopenic purpura  Microvascular thrombosis

Dr. Jonathan Scott Harrison is currently working as professor of Medicine in University of Missouri, United States. He is also working as Adjunct Faculty Member in Graduate School of Biomedical Science at Rutgers, NJ. He completed his education from The University of Illinois, Chicago. He received many certifications for Internal Medicine and Medical Oncology Hematology in the year 1987 and 1989 respectively. Dr. Jonathan Scott Harrison received many awards and honors: Commander’s Award for Public Service from the Department of the Army (80th TASS) in 2012. He is acting as Editorial Board Member and Peer Reviewer of many peer reviewed journals and authored many books, book chapters and articles.

Research: Dr. Jonathan Scott Harrison’s research interests include Normal and abnormal hematopoiesis, examining the role of the cyclin regulator p35Nck5a and the Cdk5 & MAP Kinase pathways in myeloid leukemias response to Vitamin D analog treatment (co-investigator for NIH grant RO1 CA44722-21), clinical trials in Hematologic Malignancies and investigational treatment of Hematologic disorders, and in new therapies and clinical aspects of the Sickling Hemoglobinopathies.  

Dr. Rammurti T. Kamble is Professor of Medicine in Hematology-Oncology, Cell, and Gene Therapy, Baylor College of Medicine and Methodist Hospital, Houston, TX. He graduated from Ravi Shankar University, India in 1986 with a gold medal. He obtained postgraduate residency training from prestigious Postgraduate Institute of Medical Science and Research (PGIMER) Chandigarh, India and his fellowship training in Hematology-Oncology from All India Institute of Medical Sciences (AIIMS), New Delhi. He was junior faculty in the AIIMS before joining MAMC, New Delhi University as Assistant Professor of Medicine. Between 1997 and 2001, he completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from the University of Tennessee and the University of Arkansas for Medical Sciences respectively. He has served as Assistant Professor of Medicine and Associate Director of Hematology-Oncology fellowship program at Oklahoma University Health Sciences Center (OUHSC). Dr. Rammurti T. Kamble has conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith Hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Biology of bone marrow transplantation and Bone marrow transplant.

Research: Dr. Rammurti T. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation. His clinical interests are in innovative reduced conditioning protocols, in vivo T-cell depletion and novel approaches to reduce and treat graft-versus-host disease.

Dr. Eugene Kim is Associate Professor of Surgery, Division of Pediatric Surgery in the Department of Surgery at the University of Southern California Keck School Of Medicine in Los Angeles, California. He has clinical expertise in pediatric surgical oncology, the management of chest wall deformities and anorectal malformations.  He also has expertise in extracorporeal membrane oxygenation (ECMO) as it relates to newborn pulmonary and cardiac failure.  Dr. Kim is the principal investigator of a basic science laboratory focused on novel preclinical therapeutics for the aggressive childhood malignancy, neuroblastoma.  His research interests are focused on the development and discovery of new anti-angiogenic pathways and therapies for neuroblastoma.  Specifically, Dr. Kim has expertise in VEGF biology in neuroblastoma as it relates to tumor angiogenesis.  In addition, Kim’s lab is investigating a novel cancer stem cell population in neuroblastoma and its role in tumor recurrence.  

Research: Dr. Eugene Kim’s research interest includes: Neuroblastoma Pediatric cancer Angiogenesis Cancer stem cells Vascular biology Vascular endothelial growth factor MDM2 CD114

Dr. Yun Dai is Associate Professor of Medicine in the Division of Hematology/Oncology. He received post-doc training in Molecular Biology and Biochemistry at the University of Pennsylvania, and in Hematology/Oncology and Clinical and Translational Research at the Virginia Commonwealth University. Dr. Dai’s research has been supported by RO1, R21, Multiple Myeloma SPORE, and Lymphoma SPORE grants from NCI/NIH, and awards from research foundations/societies, including Multiple Myeloma Research Foundation, Leukemia and Lymphoma Society, and V Foundation. His research has resulted in 6 multi-institutional and NCI-supported phase I or II clinical trials in treatment of patients with leukemia, lymphoma, myeloma, and other heme malignancies, parts of which have been presented at the ASCO and ASH annual meetings. Dr. Dai has served on review panels of the NIH/NCI and the Israeli-French High Council for Scientific & Technological Research, as well as the Editorial Board Member for many journals. He has extensively served as a peer reviewer for numerous research journals. He has been an active member of AACR and ASH in good-standing since 2002 and 2005, respectively. Dr. Dai received his M.D. and PhD degrees from Southern Medical University (SMU, Guangzhou, Guangdong, China), where he received training in Medicine, Histology/Cell Biology and Embryology/Development Biology. He has published 65 original research papers and 9 reviews/commentaries in peer-review journals, as well as 6 invited book chapters. His work has been presented in international conferences, including oral presentations at the AACR and ASH annual meetings.

Research: Dr. Dai’s primary research interest is in The translational and pre-clinical research of novel targeted cancer therapy, primarily focusing on hematological malignancies.

Dr. Julie Teruya-Feldstein is currently working as a Director for Hematology Fellowship program, Immunohistochemistry Laboratory, Hematopathology Service at Memorial Hospital for Cancer and Allied Diseases, New York, United States. She has attained many professional memberships. She received many honors and awards. She is a manuscript reviewer for numerous journals. She published numerous articles in various journals.

Research: Dr. Julie Teruya-Feldstein’s research interests include: Neoplastic Hematopathology, Adult and Pediatrics Lymphoma Leukemia Immunohistochemistry Molecular Diagnostics Genomics, Proteomics Myeloproliferative/Myelodysplastic Disorders Plasma cell neoplasms Transplantation

Dr. MacEwan studied Pharmacology at Glasgow and Edinburgh Universities undertaking a PhD with Dr. Rory Mitchell at the MRC Brain Metabolism Unit, University of Edinburgh. A further postdoctoral stint at Glasgow was followed by faculty position in 1996 at the University of Aberdeen.  He became the Professor of Pharmaceutical Cell Biology at the University of East Anglia in 2005, before moving to his current position of Chair in Molecular Pharmacology in the Department of Molecular & Clinical Pharmacology at the University of Liverpool – the UK’s largest Pharmacology department. He has received many honors and awards. He has received two patents. 

Research: Dr. MacEwan’s research interests include: Signal transduction mechanisms controlling cell death, proliferative and toxicological responses in human leukemia. With wide-ranging interests in cell surface receptor mechanisms, kinase pathway systems and transcription factor control mechanisms, Dr MacEwan is interested in understanding drug-resistance mechanisms and drug-toxicity mechanisms to further clinical therapeutic advances in human leukemias.

Andrew Taylor-Robinson received a BSc in microbiology (immunology major) from University College London and a PhD in parasite immunology from the University of Glasgow for work on immunity to malaria. Postdoctoral research at the Universities of Edinburgh and Glasgow, the Medical Research Council Laboratories, Fajara, The Gambia, and the Max Planck Institute for Immunobiology, Freiburg, Germany, on human and rodent malarias further developed interest in regulation of immunity to infection. Andrew Taylor-Robinson was awarded a Welcome Trust Career Development Research Fellowship at the University of Leeds and subsequently appointed to the permanent academic staff. He is a Fellow of the Higher Education Academy, Royal College of Pathologists, Society of Biology, Institute of Biomedical Science and the Australasian College of Tropical Medicine. He joined CQ University in 2012 and spent a secondment as a Professorial Research Fellow with the Health Collaborative Research Network. He is Professor of Immunology & Hematology and currently Deputy Dean (Research) in the School of Medical & Applied Sciences. Andrew has 25 years’ research experience of infectious disease immunology, with focus on malaria and other mosquito-borne diseases.

Research: His research interest includes Cardiorespiratory Medicine and Haematology - Respiratory Diseases Medical Microbiology - Medical Parasitology Medical Microbiology - Medical Virology Clinical Sciences - Infectious Diseases Medical Microbiology - Medical Bacteriology Immunology - Cellular Immunology Clinical Sciences - Otorhinolaryngology       

Dr. Dan Douer is currently a member in Memorial Sloan Kettering Cancer Center, New York, United States. He was previously worked as an Associate Professor in University of Southern California.  He received many certifications in Hematology and Internal Medicine. He has many professional Memberships in various organizations. He received many honors and awards. He acts as a reviewer for many reputed journals. He authored many book chapters and published many articles. 

Research: Dr. Dan Douer’s research interests include: Leukemia mostly acute leukemias Lymphoma Myeloma Internal Medicine

Dr. Emmanuel Andrès worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department in the University hospital of Strasbourg, France. He was awarded the French Society of Haematology, price for research in the field of anaemia related to cobalamin or folate deficiencies in 2004.

Research: Dr. Emmanuel Andrès’s research works focuses on all type of anaemia, neutropenia and thrombocytopenia, particularly drug-induced neutropenia and agranulocytosis or thrombocytopenia; haematopoietic growth factors; and cobalamin deficiencies. 

Dr. Viroj Wiwanitkit is presently working as a professor in Hainan Medical University, Thailand. He is an Editorial Board member in various international journals. He has received many academic honors. He has more than 1500 publications in International Journals and has given more than 150 presentations in international congress.

Research: Dr. Viroj Wiwanitki's research interest includes  Tropical medicine Laboratory science (biomedical) Nano science and nanotechnology Bioinformatics and medical engineering Family medicine social medicine public health

Dr. Jacek Wachowiak is currently working as a Professor in Department of Pediatric Oncology, Hematology and Transplantology, at university of Medical Sciences, Poland. He has a membership in many professional societies.  He acts as a Peer reviewer for many articles.  He performed many  investigational research projects. 

Research: Dr. Jacek Wachowiak’s research includes: Pediatric Oncology Hematology and Transplantology

Dr. Nejat Dalay is currently working as an Associate professor at Istanbul University Oncology Institute , Turkey. He previously worked as a Head of Experimental and Molecular Oncology Division. He has many publictaion

Research: Dr. Nejat Dalay’s research interests include: Molecular biology and genetics/epigenetics of head and neck cancer Characterization and analysis of circulating nucleic acids and micro RNA’s as potential biomarkers Gene expression analyses in tumors Diagnostic mutation testing in cancer 

Dr.Salah Aref is currently working as professor of Hematology in Mansoura University; Egypt. He is also working as Member in National board for promotion of Professors in Hematology. He completed his education from The Mansoura University. Dr. Salah Aref received many awards and honors:  from   Egyptian National Academy of Science and International Society of Laboratory Hematology. He is acting as Editorial Board Member and Peer Reviewer of many peer reviewed journals and authored many books.

Research: Dr.Salah Aref`s research interests include  Hematological Oncology Thalassemias Molecular Study of Hematological Disorders Angiogenesis in Hematological Malignancies

Dr. Fadia Mostafa Attia is presently working as a Professor of Clinical Pathology Department. She has a membership in many Scientific Societies and Associations. She is an Editorial Board member for many journals. She gave many paper presentations at conferences and meetings.

Research: Dr. Fadia Mostafa Attia’s research interests include: Clinical Pathology.  

Dr. Francesco Passamonti is Head of the Division of Hematology of the University Hospital of Varese, Italy. He obtained his medical degree from the University of Pavia, subsequently becoming a specialist in Hematology. He worked as Assistant Professor of Hematology at the University of Pavia and as hematologist at the Division of Hematology of Policlinico San Matteo, Pavia, Italy. He is a member of the Board of the International Working Group on Myeloproliferative Research and Treatment (IWGMRT), as well as the European LeukemiaNet Work Package 9 for MPN and the Working Party for MPN of GIMEMA. He has authored and co-authored more than 170 papers on MPN and other hematological malignancies. He collaborated to the definition of molecular basis of MPNs and he designed new prognostic models for MPNs. He performs many clinical trials with JAK2 inhibitors, HDACi and IMiDs in MPNs from phase I to phase 3 trials.  

Research: Dr. Francesco Passamonti’s research interests include: Philadelphia-negative myeloproliferative neoplasms (MPN) Polycythemia vera Essential thrombocythemia myelofibrosis  

Dr. Claudio Fozza obtained his degree in Medicine at the University of Sassari in 2000 and his Specialization in Haematology in 2004 under the supervision of Prof M. Longinotti. In 2006 he started his academic teaching at the University of Sassari, chair of Haematology, and became consultant in Haematology. From January 2005 to December 2006 he attended the Hammersmith Campus at Imperial College in London, as Honorary Clinical Assistant and Clinical Trial Coordinator at the Dept. of Haematology chaired by Prof. J Apperley and as Clinical Research Fellow, Stem Cell Biology Section, Dept. of Immunology under the supervision of Prof F. Dazzi. He published many articles. He is the Editorial Board member for many journals.    

Research: Dr. Claudio Fozza’s research interest includes T-cell receptor repertoire Regulatory T-cells Myelodysplastic Syndromes        Non Hodgkin Lymphomas

Dr. Jason X. Cheng stayed at University of Chicago to get his Hematopathology fellow under the guidance of Dr. James W. Vardiman, one of the top authorities in Diagnostic Hematopathology. He completed his fellowship training in 2010, and then became an assistant Professor in University of Michigan at Ann Arbor where he was the head of Epigenetics Laboratory. Dr. Cheng came back to become a faculty in the Hematopathology Section at University of Chicago in 2013. He has quite a few scientific publications and a patent issued by the U.S. patent agency. He also had multiple awards including Cancer Research Foundation Young Investigator Award, the society for Hematopathology Pathologist-in-Training Award, the Paul E. Strandjord Young Investigator Award from Academy of Clinical Physicians and Scientists, the Robert E. Priest Fellowship, …etc.

Research: Dr. Jason X. Cheng’s research interest includes: Genetic and epigenetic controls of hematopoiesis Hematopoietic stem cell differentiation and lineage specification. Pathogenesis of anemia Myeloproliferative neoplasms Myelodysplastic syndrome Leukemia

Dr. Shigemi Matsuyama is presently working as an Associate Professor in Department of Medicine, Division of Hematology/Oncology in Case Western Reserve University. He has a membership in many professional societies. He has received many honors and awards. Dr. Shigemi Matsuyama is also an Editorial board member for the journal of Experimental Biology and Medicine. He acts as a Peer reviewer for many journals. He gave his service to many medical schools, hospitals and cancer centers. He published many articles. He participated in many invited seminars.

Research: Dr. Shigemi Matsuyama’s research interests include:  Apoptosis Bcl-2 family proteins Aging DNA repair DNA damage response Cancer Cell Biology Cell Death Regulation  Cell Penetrating Peptide.  Cancer biology

Dr. Asim Kalkan working in Department of Emergency Medicine, RTE University, Turkey. He has a membership in Emergency Medicine Physicians Association of Turkey. The recent ones include National Emergency Medicine Congress, Antalya, 2013. National Emergency Medicine Congress, Antalya, 2014. He published many articles.

Research: Dr. Asim Kalkan’s research interest is in Emergency Medicine

Dr. Luca Arcaini is Assistant Professor of Hematology at University of Pavia School of Medicine, Pavia, Italy. He has authored and co-authored 126 papers on hematological malignancies.

Research: Dr. Luca Arcaini expertise in non-Hodgkin’s lymphomas.

Dr. Richa Aror is an Assistant professor in the Department of Radiology in the  Nizam’s Institute of Medical Sciences, Hyderabad, India. She did her training from M.D University Rohtak and All India Institute of Medical Sciences, New Delhi. She is also alumni of National university of Singapore and fellow of Royal college of Radiologists, UK. Her research interests include Cross-sectional imaging, Musculoskeletal Radiology including imaging of bone marrow. She has many publications to her credit and has written a book for Radiology trainees ‘Comprehensive Revision of Radiology for FRCR 2B’.

Research: Dr. Richa Arora’s research interests focuses on Medical Sciences.

Dr. Singh is Principal Scientist and Head of Toxicogenomics and Predictive Toxicology Division at the CSIR-Indian Institute of Toxicology Research, Lucknow, India. He has authored around 60 research publications in acclaimed journals. He is on the editorial board of over 10 journals and is ad-hoc reviewer of over 50 venerated journals and funding agencies.

Research: Dr. Singh’s current research interests include: Development of Peripheral Biomarkers of Parkinson’s disease and Parkinsonism Elucidation of Molecular Mechanism of Pesticide(s)-induced Parkinsonism 

Dr. Saeid Abroun is presently working as an Associate professor in Hematology and Blood Banking Department, Tarbiat Modares University, Iran. He has completed many theses. He published many articles. And presently he is acting as a Director for some thesis. He is doing a research on differentiation of hematopoietic Stem Cell to Osteoclast and many more.

Research: Dr. Saeid Abroun’s research interests include: Molecular Mechanism of Multiple Myeloma Cell Growth Cancer Stem Cell Stem Cell Differentiation

Dr. Seyed Mahmoud Hashemi is currently working as an Assistant Professor of Immunology in Shahid Beheshti University of Medical Sciences, Tehran, Iran. He authored many papers on immunology autoimmunity and stem cells. He has received many awards. He is acting as a peer reviewer for many journals.

Research: Dr. Seyed Mahmoud Hashemi’s research interests include: Immunomodulatory effects of mesenchymal stem cells Cell therapy and stem cell therapy in autoimmune disease Mesenchymal stem cells